. . . . . . . . . "\"* Medullary Thyroid Carcinoma VICTOZA is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). * Hypersensitivity VICTOZA is contraindicated in patients with a prior serious hypersensitivity reaction to VICTOZA or to any of the product components. Serious hypersensitivity reactions including anaphylactic reactions and angioedema have been reported with VICTOZA [see Warnings and Precautions 5.6 VICTOZA is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (4) VICTOZA is contraindicated in patients with a prior serious hypersensitivity reaction to VICTOZA or any of the product components (4)\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "d9Vlfp1Vf1jxuIUpZILvARde79XAv+EnBWP3LJAqM2F1QeU2FO/JoIHztX8vACMkq1yUE/RPp1OQpoiL9WtGwokAvKeg+5xcq1AWXHJlapZvfP6rJmCMXFxpb1AUxK6O9ecjj2uEkXGZp8/8cHE406TVAaYYRWsFrwkYLRqnuFY=" . . "2021-08-23T19:14:26.265+02:00"^^ . . . . .